Paragon 28 PE Ratio 2020-2022 | FNA

Current and historical p/e ratio for Paragon 28 (FNA) from 2020 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Paragon 28 PE ratio as of August 15, 2022 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Paragon 28 PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-08-16 19.23 inf
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.568B $0.147B
Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $236.833B 24.12
Edwards Lifesciences (EW) United States $64.933B 45.94
Alcon (ALC) Switzerland $34.110B 28.88
STERIS (STE) Ireland $21.399B 26.58
Teleflex (TFX) United States $11.944B 19.03
Fresenius Medical Care AG KGaA (FMS) Germany $10.930B 10.08
Globus Medical (GMED) United States $6.721B 34.28
Penumbra (PEN) United States $6.619B 794.04
Integer Holdings (ITGR) United States $2.525B 19.75
Glaukos (GKOS) United States $2.496B 0.00
Nevro (NVRO) United States $1.877B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.400B 21.44
Artivion (AORT) United States $0.937B 89.42